Inactive

Amendment 0003: The attached amendment provides responses to additional vendor-submitted questions. Amendment 0002: The attached amendment provides responses to vendor-submitted questions; revises the... Amendment 0003: The attached amendment provides responses to additional vendor-submitted questions. Amendment 0002: The attached amendment provides responses to vendor-submitted questions; revises the RFP document and RFP Attachments 9 and 10 (Sample Task Order #2 and #3 SOWs); and extends the response deadline to 10/11/2024 at 5 pm ET. Phase I Clinical Trials for Development of Small Molecule and Biologics Therapeutics

Inactive

This pre-solicitation notice for Request for Proposals (RFP) NO. 75N95024R00086, entitled: "Phase I Clinical Trials for Development of Small Molecule and Biologics Therapeutics" has been extended unti... This pre-solicitation notice for Request for Proposals (RFP) NO. 75N95024R00086, entitled: "Phase I Clinical Trials for Development of Small Molecule and Biologics Therapeutics" has been extended until August 19, 2024, at 3 pm ET. It is anticipated the RFP will be issued via www.SAM.gov on or around this date.